Vang, Tong – Trademark Portfolio

Entity Type: 01

Vang, Tong holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include URICINEX, HYPEREXOL, and PROLIPAMY. The owner is based in Grand Rapids, MI.

Apt. 9D

2872 Marshall Avenue SE

Grand Rapids, MI 49508

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Vang, Tong's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (1 filing)

Clothing, footwear, headgear

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Vang, Tong have?

Vang, Tong has 14 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned, 8 cancelled.

What trademark classes does Vang, Tong file in?

Vang, Tong files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Vang, Tong's most well-known trademarks?

Vang, Tong's registered trademark portfolio includes well-known marks such as URICINEX, HYPEREXOL, and PROLIPAMY. These are among 3 currently registered trademarks in the portfolio.

What is Vang, Tong's trademark registration success rate?

Vang, Tong has a 21% trademark registration rate, with 3 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.